FDA Investigator Robert Barbosa
Robert Barbosa has conducted inspections on 1 sites in 1 countries as of 15 Nov 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
15 Nov 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Robert Barbosa:
Alan L Truong,
Andrew J Barrowcliff,
Charles Yuanchia Kuo, PhD,
Cristina Ausin Moreno, PhD,
Diane L Raccasi,
Eboni S Funderburk,
Edwin Jao,
Emilie E Kahn,
Esther C Broner, PhD,
Hyung Yul Lee,
Jacob G Lutz,
James A Lane,
Jeffrey D Meng,
Jon P Antoniou,
Joslyn K Brunelle, PhD,
LCDR Sean Byrd,
Logan T Williams,
Maria Cruz Fisher,
Meisha R Sampson,
Meisha Waters,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele Perry Williams,
Muna Algharibeh,
Nicholas L Paulin,
Rabia Ballica, PhD,
Rafeeq A Habeeb,
Robert M Barbosa,
Sandra A Boyd,
Sargum C Sood,
Scott R Nichols, PhD,
Sneha S Patel,
Timothy J Schmidt,
Vaishali J Patel,
Wayne E Seifert,
Wendy G Tan, PhD,
Yanming An, PhD,
Yuan Chia Kuo
Robert Barbosa's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2012 | EIR | Catalent Indiana, LLC - EIR, 2012-02-24 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more